LFST — Lifestance Health Cashflow Statement
0.000.00%
Last trade - 00:00- $2.37bn
- $2.57bn
- $1.06bn
- 59
- 49
- 56
- 55
Annual cashflow statement for Lifestance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.67 | -38.1 | -307 | -216 | -186 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.532 | 5.75 | 287 | 233 | 145 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.99 | -0.753 | 2.14 | -16.9 | -33.7 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 17 | -8.53 | 9.42 | 52.8 | -16.9 |
| Capital Expenditures | -14.3 | -38.1 | -94.5 | -79.3 | -40.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -59.1 | -823 | -99.6 | -60.2 | -19.8 |
| Acquisition of Business | |||||
| Cash from Investing Activities | -73.4 | -861 | -194 | -139 | -60.3 |
| Financing Cash Flow Items | -6.99 | 601 | -11.2 | -20.7 | -7.86 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 48.5 | 912 | 314 | 47.3 | 47.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.86 | 42.6 | 129 | -39.4 | -29.8 |